SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-23-001696
Filing Date
2023-02-10
Accepted
2023-02-09 21:17:34
Documents
16
Effectiveness Date
2023-02-10

Document Format Files

Seq Description Document Type Size
1 S-8 vktx-s8.htm S-8 96344
2 EX-5.1 vktx-ex51_6.htm EX-5.1 29114
3 EX-23.1 vktx-ex231_7.htm EX-23.1 3369
4 EX-FILING FEES vktx-exfilingfees_8.htm EX-FILING FEES 20456
5 GRAPHIC gzjosjj23q5v000001.jpg GRAPHIC 631
6 GRAPHIC gzjosjj23q5v000004.jpg GRAPHIC 635
7 GRAPHIC gzjosjj23q5v000010.jpg GRAPHIC 635
8 GRAPHIC gzjosjj23q5v000003.jpg GRAPHIC 639
9 GRAPHIC gzjosjj23q5v000011.jpg GRAPHIC 631
10 GRAPHIC gzjosjj23q5v000007.jpg GRAPHIC 647
11 GRAPHIC gzjosjj23q5v000012.jpg GRAPHIC 631
12 GRAPHIC gzjosjj23q5v000005.jpg GRAPHIC 970
13 GRAPHIC gzjosjj23q5v000008.jpg GRAPHIC 970
14 GRAPHIC gzjosjj23q5v000002.jpg GRAPHIC 631
15 GRAPHIC gzjosjj23q5v000009.jpg GRAPHIC 635
16 GRAPHIC gzjosjj23q5v000006.jpg GRAPHIC 635
  Complete submission text file 0001564590-23-001696.txt   163615
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269675 | Film No.: 23608294
SIC: 2834 Pharmaceutical Preparations